Aaron Cravens Email

CEO . Revel Pharmaceuticals

Current Roles

Employees:
9
Revenue:
$697.5k
About
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.
Revel Pharmaceuticals Address
953 Indiana Street
San Francisco, CA
United States
Revel Pharmaceuticals Email

Past Companies

Revel PharmaceuticalsChief Executive Officer
xCella BiosciencesConsultant
Antheia, Inc.Consultant

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.